Snowball logo
logo
BO1_logo

BioCryst Pharmaceuticals Inc

€7.244+€0.244Β  (3.49%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
157.2270.8331.4450.7874.8940.6
COGS
7.2646.5944.48112.2719.0720.93
Gross Profit
149.9264.2326.9438.4855.8919.7
Operating Expenses & Income
Operating Income
(177.7)(148.4)(103.7)(2.543)341(313.2)
Total Operating Expenses
334.9419.3435.1453.3533.81,253.8
R&D Expenses
208.8253.3216.6174.6166.1895.5
Selling General & Admin Expenses
118.8159.4214.1266.3348.6337.3
Earnings from Continuing Operations
Interest Expense
(59.29)(99.09)(108.2)(98.52)(78.87)(75.29)
Interest Income
0.0625.12715.7814.7510.679.818
Income Tax Expense
2.2532.733----
Net Income
Net Income
(184.1)(247.1)(226.5)(88.88)263.9(384.7)
Supplemental
EBIT
(177.7)(148.4)(118)11.56346.3(305.9)
EBITDA
(122.5)(145.3)(116.3)12.81347.7(304.2)
In millions of EUR, except % and values per 1 share